Innovation & The Economy: Beyond the Headlines

By targeting the physical mechanics of tumors rather than biochemical pathways, Myosin Therapeutics aims to conquer glioblastoma and court investors in NYC.

Evotrex is betting its motorized, hybrid-powered PG5 trailer can cure EV towing anxiety. But can a well-funded startup disrupt the entrenched RV industry?

Alimentiv and IBUS are scaling noninvasive intestinal ultrasound to replace costly endoscopies, solving a major bottleneck in global pharmaceutical research.

A new partnership between Sionic and Unfiltered Ink Media aims to bring FedNow to restaurant checkouts, promising operators a 60% cut in processing fees.

ORANGE JUICE is merging private equity rollups, Bitcoin treasuries, and elite AI. The hire of Elias Martinez Cohen reveals a radical new corporate playbook.

By blending native Salesforce architecture with autonomous AI, Klient Insights is eliminating reporting bottlenecks and challenging legacy enterprise pricing models.

Sizzle's new AI host at the Sheraton Universal Hotel signals a shift away from costly in-room tablets toward browser-based, multilingual synthetic staff.

New real-world data reveals a 34% drop in hospitalizations for heart failure patients using CCM therapy, bridging a crucial gap in cardiac care economics.

Ahead of VF Corp's Q2 FY2027 earnings, all eyes are on Vans' turnaround efforts and The North Face's momentum as early indicators for holiday retail demand.

Medela's new Drainology hub aims to standardize post-op chest drainage, highlighting the growing economic influence of medtech in clinical education.

AmyriAD Therapeutics is betting an all-stock deal can turn a missed Phase 2b endpoint into a breakthrough for cognitive impairment in schizophrenia.

Olyzon’s new agentic orchestration platform promises to solve CTV's fragmentation crisis, but can AI truly manage millions in ad spend without going rogue?

As corn prices rise, the used farm equipment market is rebounding. But a sharp divergence in construction and trucking reveals a complex economic reality.

As Peptides Canada launches its domestic supply platform, we explore the regulatory tightrope and supply chain dynamics reshaping the nation's biotech landscape.

Mink Ventures completes its maiden drill program at the Rankin property near Timmins, intersecting sulphides and accelerating Ontario's battery metals push.

As Resmed prepares to report its Q1 FY2027 earnings, investors are watching how the medical device giant navigates GLP-1 disruptions and AI-driven growth.

As state and local agencies face pressure to modernize, a new single-award cooperative contract bypasses lengthy RFP cycles to accelerate tech adoption.

As retail trading platforms move from cluttered dashboards to chat-based execution, Leverate’s new AI assistant balances efficiency with strict broker compliance.

Vivint’s new AI tool uses whole-home data to cut HVAC costs, signaling a shift toward virtual power plants but raising fresh privacy concerns.

Aurzen’s new Basquiat-branded pocket projector signals a broader economic shift: in a crowded hardware market, cultural cachet is the ultimate differentiator.